You are here:Home-ADCs and PROTACs-PROTAC-BI 1810284
BI 1810284

Chemical Structure : BI 1810284

CAS No.: 2913177-47-4

BI 1810284 (ACBI2, BI-1810284, BI 01810284)

Catalog No.: PC-20464Not For Human Use, Lab Use Only.

BI 1810284 (ACBI2, BI 01810284) is a potent, selective and orally bioavailable VHL-recruiting PROTAC degrader of SMARCA2 (DC50=1 nM in RKO cells), 30-fold selectivity over SMARCA4.

Packing Price Stock Quantity
100 mg Get quote
200 mg Get quote
500 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

BI 1810284 (ACBI2, BI 01810284) is a potent, selective and orally bioavailable VHL-recruiting PROTAC degrader of SMARCA2 (DC50=1 nM in RKO cells), 30-fold selectivity over SMARCA4.
BI 1810284 (80 mg/kg, oral) induces lung cancer tumour growth inhibition in A549 tumour bearing mice.

Physicochemical Properties

M.Wt 1063.19
Formula C57H69BrFN7O5S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-Pyrrolidinecarboxamide, N-[(1S,4S)-6-[4-(4-bromo-7-cyclopentyl-5,7-dihydro-5-oxobenzimidazo[1,2-a]quinazolin-9-yl)-1-piperidinyl]-4-methyl-1-[4-(4-methyl-5-thiazolyl)phenyl]hexyl]-1-[(2S)-2-[2-(1-fluorocyclopropyl)-2-oxoethyl]-3,3-dimethyl-1-oxobutyl]-4-hydroxy-, (2S,4R)-

References

1. Christiane Kofink, et al. Nat Commun. 2022 Oct 10;13(1):5969.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: